What is the average price target for CARTER'S INC (CRI) stock?
13 analysts have analysed CRI and the average price target is 35.5 USD. This implies a price increase of 1.94% is expected in the next year compared to the current price of 34.82.
CARTER'S INC (CRI) Forecast, Price Target & Analyst Ratings
NYSE:CRI • US1462291097
Current stock price
34.82 USD
+0.25 (+0.72%)
At close:
34.82 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CARTER'S INC (CRI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 23, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.09
- Revenue Estimate
- 663.03M
Price Target Details & History
Consensus Price Target and Range
Mean target
$35.50
Upside
+ 1.94%
From current price of $34.82 to mean target of $35.50, Based on 13 analyst forecasts
Low
$25.25
Median
$30.60
High
$52.50
Price Target Revisions
1 Month
4.19%
3 Months
17.97%
Price Target Summary
13 Wall Street analysts provided a forecast for the next 12 months for CRI. The average price target is 35.5 USD. This implies a price increase of 1.94% is expected in the next year compared to the current price of 34.82.
The average price target has been revised upward by 17.97% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
49.23%
CRI was analyzed by 13 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about CRI.
In the previous month the buy percentage consensus was at a similar level.
CRI was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-26 | Needham | Initiate | Hold |
| 2026-02-19 | UBS | Maintains | Neutral -> Neutral |
| 2026-01-21 | Citigroup | Upgrade | Neutral -> Buy |
| 2026-01-13 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-12-11 | Goldman Sachs | Initiate | Sell |
| 2025-10-28 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-28 | Barclays | Maintains | Underweight -> Underweight |
| 2025-10-28 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-10-28 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-14 | Barclays | Maintains | Underweight -> Underweight |
| 2025-07-29 | Barclays | Maintains | Underweight -> Underweight |
| 2025-07-28 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-14 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-04-30 | Wells Fargo | Downgrade | Equal-Weight -> Underweight |
| 2025-04-28 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-28 | Barclays | Initiate | Underweight |
| 2025-02-26 | UBS | Maintains | Neutral -> Neutral |
| 2025-02-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-26 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-11-12 | Citigroup | Upgrade | Sell -> Neutral |
| 2024-10-28 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-09 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-07-29 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-04-24 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-04-18 | Citigroup | Maintains | Sell -> Sell |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 23, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.09
- Revenue Estimate
- 663.03M
- Revenue Q2Q
- 5.27%
- EPS Q2Q
- -85.64%
- Number of Analysts
- 7
Next Earnings Revisions
Revenue (1 Month)
1.88%
Revenue (3 Months)
2.29%
EPS (1 Month)
-58.33%
EPS (3 Months)
-64.12%
Next Earnings Summary
CRI is expected to report earnings on 4/23/2026. The consensus EPS estimate for the next earnings is 0.09 USD and the consensus revenue estimate is 663.03M USD.
The next earnings revenue estimate has been revised upward by 2.29% in the past 3 months.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.946B -8.31% | 2.844B -3.45% | 2.898B 1.91% | 3.029B 4.50% | 3.057B 0.92% | 3.071B 0.46% | |
| EBITDA YoY % growth | 387.544M -14.51% | 342.654M -11.58% | 199.196M -41.87% | 245.98M 23.49% | 279.92M 13.80% | 348.48M 24.49% | |
| EBIT YoY % growth | 323.405M -16.67% | 284.728M -11.96% | 143.933M -49.45% | 184.21M 27.98% | 206.56M 12.13% | 218.78M 5.92% | |
| Operating Margin | 10.98% | 10.01% | 4.97% | 6.08% | 6.76% | 7.12% | |
| EPS YoY % growth | 6.22 -10.12% | 6.07 -2.41% | 3.47 -42.83% | 3.10 -10.55% | 3.54 14.06% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 -85.64% | -0.05 -131.19% | 0.69 -6.32% | 1.43 -24.52% |
| Revenue Q2Q % growth | 663.03M 5.27% | 603.34M 3.08% | 763.09M 0.69% | 844.61M -8.74% |
| EBITDA Q2Q % growth | 40.069M 1.81% | 16.102M -47.82% | 52.187M -25.10% | 59.519M -57.47% |
| EBIT Q2Q % growth | 15.366M -41.13% | 4.697M 16.15% | 40.612M 39.59% | 73.695M -12.99% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
1.65%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
25.01%
EBIT Next 5 Year
N/A
CARTER'S INC / CRI Forecast FAQ
When does CARTER'S INC (CRI) report earnings?
CARTER'S INC (CRI) will report earnings on 2026-04-23.
What are the consensus estimates for CRI stock next earnings?
The consensus EPS estimate for the next earnings of CARTER'S INC (CRI) is 0.09 USD and the consensus revenue estimate is 663.03M USD.
What is the expected long term growth rate for CRI stock?
The expected long term growth rate for CARTER'S INC (CRI) is 1.65%.